Bright Minds Biosciences ... (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

32.68

-0.03 (-0.09%)

At close: Apr 28, 2025, 3:59 PM

31.00

-5.14%

Pre-market: Apr 29, 2025, 04:07 AM EDT

Bright Minds Biosciences Cash Flow Statement

Financials in CAD. Fiscal year is October - September.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Net Income	-1.07M	-2.8M	-3.56M	-5.24M	-6.72M	-7.37M	-8.81M	-10.01M	-12.44M	-14.96M	-14.87M	-15.75M	-12.76M	-8.65M	-6.19M	-2.68M	-1.2M	-480.38K	-77.76K	-48.14K	-31.41K
Depreciation & Amortization	76.78K	73.36K	72.45K	72.45K	72.45K	72.45K	60.38K	42.26K	24.15K	6.04K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	797.21K	839.77K	1.03M	1.08M	886.94K	1.15M	781.55K	837.39K	1.1M	875.06K	1.22M	1.19M	905.13K	880.62K	665.35K	404.55K	397.71K	161.3K	n/a	n/a	n/a
Other Working Capital	-133.59K	556.08K	140.64K	42.38K	472.83K	-1.05M	210.19K	-151.44K	-39.19K	771.94K	119.95K	781.67K	387.67K	510.62K	225.26K	176.86K	-60.08	-78.29	n/a	n/a	n/a
Other Non-Cash Items	-898.74K	727.6K	743.76K	786.7K	2.01M	2.02M	1.97M	1.97M	-25.11K	-223.54K	-332.4K	-43.43K	-46.62K	144.75K	297.16K	3.96K	134.73	115.09	-0.00	-60	-28.32
Deferred Income Tax	n/a	42.3K	205.73K	75.26K	75.26K	32.97K	-136.51K	-6.04K	-6.04K	-6.04K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-658.6K	39.81K	-308.93K	-477.5K	487.07K	-930.33K	170.95K	-8.4K	51.23K	726.31K	133.5K	641.52K	237.98K	306.08K	83.65K	126.4K	-35.36K	30.68K	n/a	-49.42K	-28.32K
Operating Cash Flow	-2.52M	-1.85M	-2.58M	-4.48M	-3.19M	-5.03M	-5.96M	-7.17M	-11.3M	-13.59M	-13.85M	-13.96M	-11.66M	-7.32M	-5.14M	-2.15M	-840.03K	-288.39K	-77.76K	-97.56K	-59.73K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	22.88	n/a	n/a	n/a	-22.88	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	-11.19M	-11.19M	-11.19M	-11.19M	n/a	n/a	n/a	n/a	22.88	n/a	n/a	n/a	-22.88	n/a	n/a	n/a	n/a
Debt Repayment	-91.56K	-89.73K	-87.52K	-87.05K	-86.58K	-86.11K	-39.63K	-18.14K	3.35K	24.84K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-9.7	-9.7	-9.7	-9.7	n/a	-10	-10	-10	-10	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.44M	302.00	n/a	n/a	n/a	1.06M	2.06M	2.07M	2.08M	1.14M	122.23K	-435.32K	-1.63M	-1.73M	-1.72M	-1.17M	22.88K	60.00	60.00	60.00	60.00
Financial Cash Flow	51.97M	810.57K	812.48K	812.95K	813.42K	2.19M	7.28M	7.31M	7.33M	5.2M	122.23K	-435.32K	24.3M	26.06M	26.99M	27.53M	2.88M	1.01M	81.74K	91.74K	60.00
Net Cash Flow	51.14M	-1.03M	-1.94M	-3.74M	-13.64M	-14.07M	-9.7M	-10.99M	-3.91M	-8.13M	-13.37M	-13.98M	13.05M	18.96M	21.92M	25.38M	2.04M	719.94K	3.92K	-5.88K	-59.73K
Free Cash Flow	-2.52M	-1.85M	-2.58M	-4.48M	-3.19M	-5.03M	-5.96M	-7.17M	-11.3M	-13.59M	-13.85M	-13.96M	-11.66M	-7.32M	-5.14M	-2.15M	-840.03K	-288.39K	-77.76K	-97.56K	-59.73K